Cardiovascular prognosis in stable patients with amyloidosis: a novel and simple risk score.

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Doctor Marco Maria Dicorato

Bari Polyclinic Consortium University Hospital, Bari (Italy)

8 More presentations in this session

Presentation thumbnail

Discussant - Cardiac amyloidosis (3)

Presentation thumbnail

Evaluating diagnostic scoring systems for early detection of transthyretin amyloidosis in patients with HFpEF and left ventricular hypertrophy

Doctor D. Faro (Catania, IT)

Presentation thumbnail

Detection of arrhythmias in patients with transthyretin cardiac amyloidosis

Doctor I. Simkova (Olomouc, CZ)

Presentation thumbnail

Deep screening unveils hidden cardiac amyloidosis: carpal tunnel syndrome as a gateway to early transthyretin cardiac amyloidosis diagnosis

Doctor S. Yoshida (Kanazawa, JP)

Presentation thumbnail

Prevalence of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: the RETTRACE study

Doctor D. Tsilakis (Athens, GR)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Cardiac amyloidosis (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Impact of the non-invasive diagnostic algorithm on clinical presentation and prognosis in a nationwide multicentric light-chain and transthyretin-related cardiac amyloidosis cohort

Congress Presentation

Feature tracking-cardiovascular magnetic resonance to predict major adverse cardiovascular events in patients with cardiac amyloidosis

Congress Presentation

Validation of two clinical scores for transthyretin amyloid cardiomyopathy in a mediterranean cohort of patients at risk

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources